TW470643B - A sevoflurane-containing article and methods for storing sevoflurane - Google Patents

A sevoflurane-containing article and methods for storing sevoflurane Download PDF

Info

Publication number
TW470643B
TW470643B TW88105523A TW88105523A TW470643B TW 470643 B TW470643 B TW 470643B TW 88105523 A TW88105523 A TW 88105523A TW 88105523 A TW88105523 A TW 88105523A TW 470643 B TW470643 B TW 470643B
Authority
TW
Taiwan
Prior art keywords
container
polyethylene
lid
sevoflurane
opening
Prior art date
Application number
TW88105523A
Other languages
Chinese (zh)
Inventor
Mary Jane Flanmet-Garcia
Steve H Chang
Keith R Cromack
Joan Garapolo
David Loffredo
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/205,460 external-priority patent/US6162443A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of TW470643B publication Critical patent/TW470643B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Laminated Bodies (AREA)

Abstract

A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.

Description

470643 五、發明說明(l) 本申請為1 9 9 8年元月9曰歸檔的美國專利申請系^ 0 9/004, 792號之部分補充及1 998年元月9日歸二二, •c,山 邱榷的美國專 利申請系列0 9/0 04, 876號之部分補充。 發明背景 本發明係關於供吸入性麻醉劑使用之容考搜六 〜俘吸入用府 醉劑之方法。特定地說’本發明係導向於由以容器壁二 傳遞提供障礙的、不與容器内所含的吸入麻醉二庙^ 物質所構成的容器。 Μ ^反應的 氟醚吸入麻醉 甲基)乙基醚), 醚),異氟烷(1 -烷(2, 2-二氣-1, (desf1urane )(2 裝於由玻璃構成 醉效果,但現一 可能會交互作用 一般相信是由於 酸有空執可接受 基(-C-〇-C~F)反 的降解可導致降 現在裝此等氟 物料含二氧化矽 玻璃以其容器壁 遞,並防止其他 劑如七氟醚(氟曱基-2, 2, 2 鼠—(三氟 安氟醚(2-氯-1,1,2 -三氟乙基二i曱基 氣-2,2,2 -二氣乙基二氟曱基_),甲氧i 1-二氟乙基甲基醚),及得氟醚 -二氟曱基1,2’2, 2-四氟乙基醚),一般是 的容器内。雖則此等氟醚劑顯示具極佳麻 發現在特定條件下此等氟醚劑與玻璃容^ ,因而促進氟醚劑的降解。此種交互作; 玻祝谷器物料中含路易士酸所致。路易士 未共享電子對’是以可與氟醚劑的α氟鱗 應。此等氟醚劑在有路易士酸存在時發生 解產物如氫氟酸的產生。 _劑所用的玻璃物料稱作丨丨I型玻璃。此 ,氫氧化鈣,氫氧化鈉及氧化鋁。π丨型 :礙汽的傳遞,因而防止氟醚劑由該處傳 "飞進入其内。但破螭物料如111型玻璃内470643 V. Description of the Invention (l) This application is a partial supplement to the US patent application filed on January 9, 1998, ^ 0 9/004, 792, and dated January 22, 998, to 22, • c. Supplemented by Shan Qiuyi's U.S. Patent Application Series 0 9/0 04, 876. BACKGROUND OF THE INVENTION The present invention relates to a method for the use of inhaled anesthetics, such as narcotics, to capture inhalants. In particular, the present invention is directed to a container composed of a substance that provides an obstacle to the transmission through the container wall and does not interact with the inhaled anesthetic substance contained in the container. Reacting fluoroether inhaled anesthesia methyl) ethyl ether), ether), isoflurane (1-alkane (2, 2-digas-1, (desf1urane)) (2 packed in glass made of drunk effect, but The current possible interaction is generally believed to be due to the reverse degradation of the acid with a vain acceptable group (-C-〇-C ~ F), which can lead to the loading of these fluorine materials containing silica glass with its container wall. And prevent other agents such as sevoflurane (fluorofluorenyl-2, 2, 2 rat — (trifluoroanflurane (2-chloro-1,1,2, trifluoroethyldifluorinyl-2,2 , 2-difluoroethyldifluorofluorenyl group), methoxy i 1-difluoroethyl methyl ether), and fluoroether-difluorofluorenyl group 1,2'2,2-tetrafluoroethyl ether ), Generally in a container. Although these fluoroether agents show excellent hemp found that under certain conditions these fluoroether agents have a glass capacity ^, thus promoting the degradation of fluoroether agents. Such interactions; The material is caused by the presence of Lewis acid. The electron pair that is not shared by Louis is based on the alpha fluorine scale that can interact with the fluoroether agent. These fluoroether agents produce decomposition products such as hydrofluoric acid in the presence of Lewis acid _ The glass material used by the agent is called丨 丨 Type I glass. This is calcium hydroxide, sodium hydroxide, and alumina. Π 丨 Type: Hinders vapor transmission, thus preventing the fluoroether agent from passing there and flying into it. But broken materials such as 111 Inside glass

第6頁 470643 五、發明說明(2) ' " ------—, ^3的氧化雀呂纟直接曝露於氟醚劑時有路易士酸的作 用,因而促使_劑降解。此種降 例如氫氟酸,會腐蝕玻璃交薄“ h ^的1牛解產物’ 化叙晚+於翁w 玻璃器的内表面,因而有更多的氧 於某些$形下,、ΐ i物’進一步促進說鍵化合物的降解。 構^ i ^ |生的降解產物可能破壞玻璃容器的結 你丨ί去曾ί人對抑制玻璃與各種化學劑的反應作過努力。 ;用^ 1 了解到,玻璃容器表面上有;;多 使用中是不能接受的。 丁 ρ牡旰夕 此外,玻璃容器也有破碎的顧慮。 =持拿過程中或掉落或其他受到足夠力量在, 碎會使曝露於玻璃容器内容物的 11 麻醉劑蒸發得很快…,如果玻璃容入 :醚Μ破碎時須使鄰近破碎 :3 或病房,内的人員撤退。 匕如手術室 為避免破峙所作的努力一般是在玻璃瓶外面 =面用聚乙稀氣(PVC)或合成熱塑樹脂如及觸ε產物 J Nemours and ^叩已叩的註冊商品名)作冷. 種努力增加容器的成本,並且在麻=作塗 的’也不能克服上述有關降解的問 ;盈 璃裝含敗越的吸入麻醉劑時會發生的。牛解疋在用破 基於此等理+ _ , , ^ 器以儲存,運幹及C3 %以外的物料所構成的容 運輸及杈运吸入麻醉劑’從而避免上述破心Page 6 470643 V. Description of the invention (2) '" --------, ^ 3 The oxidized queen lutein has the effect of Lewis acid when it is directly exposed to the fluoroether agent, thus promoting the degradation of the agent. Such a drop, such as hydrofluoric acid, will corrode the glass thinner "h ^ 1 Newton's decomposition product + chemical late + Yu Weng w glassware's inner surface, so there is more oxygen in some $, Ii 'further promotes the degradation of bonding compounds. Structural degradation products may destroy the junction of glass containers. People have worked hard to inhibit the reaction of glass with various chemical agents. Use ^ 1 I understand that there are on the surface of the glass container; it is unacceptable in many uses. In addition, the glass container also has concerns about breaking. = During holding or falling or other strong forces, broken will cause 11 Anesthetics that are exposed to the contents of glass containers evaporate quickly. If the glass contains: Ether M, the adjacent parts must be broken: 3 or the patient in the ward retreats. Daggers are like the efforts made by the operating room to avoid breakage. It is cold outside the glass bottle with polyethylene (PVC) or synthetic thermoplastic resin such as the product of contact with ε (J Nemours and ^ 叩叩 叩), which is an attempt to increase the cost of the container, and = Smeared 'can't overcome the above It will happen when Yingli is loaded with inhaled anesthetic containing vanilla. Niu Jiechi uses the + +, ^ device based on this principle to store, transport dry, and transport by volume other than C3%. And transport inhaled anesthetics' to avoid the above heartbreaking

470643 5r明說明(3) 器的缺點。較佳的物料不含促使吸入麻醉劑降解的路易士 酸,能有足夠的障礙不使汽體進入或流出,與玻璃容器相 比能增加容器破碎的抗力。 本發明概述 本發明導向於一種醫藥產物。此產物包括由含一或多種 聚丙烯,.聚乙烯,及離子鍵樹脂的物質構成的容i。此容 器界定内部空間,於此空間内裝有容積的含氟醚的吸入麻 醉齊|J。 於一具體實施例中,本發明導向於醫藥產物,其中界定 内部空間的容器有鄰於内部空間的内表面。此容器的内表 面係由含一或多種聚丙烯,聚乙烯,及離子鍵樹脂的物質 構成。容積的含氟醚的吸入麻醉劑裝於此容器的内部空間 内。 本發明還導向於儲存吸入麻醉劑的方法。此法包括提供 預定容積的含氟醚的吸入麻醉劑的步驟。也提供一種容 器,此容器是由含一或多種聚丙烯,聚乙烯,及離子鍵樹 脂的物質構成。此容器界定内部空間。預定容積的含氟醚 的吸入麻醉劑即置於此容器的内部空間内。 於本發明方法的一具體實施例中,提供預定容積的含氟 醚的吸入麻醉劑。此外,提供有界定内部空間的内表面的 容器。此容器的内部表面是由含一或多種聚丙烯,聚乙 烯,及離子鍵樹脂的物質構成。預定容積的含氟醚的吸入 麻醉劑即置於此容器的内部空間内。 圖解簡述470643 5r clearly explains (3) the disadvantages of the device. The preferred material does not contain Lewis acid, which promotes the degradation of inhaled anesthetics, has sufficient barriers to prevent vapors from entering or exiting, and can increase the resistance to container breakage compared to glass containers. SUMMARY OF THE INVENTION The present invention is directed to a pharmaceutical product. The product includes a container made of a substance containing one or more polypropylene, polyethylene, and ionomer resin. This container defines an internal space in which a volume of fluoroether-containing inhaled anaesthetic | J is provided. In a specific embodiment, the present invention is directed to a pharmaceutical product, wherein a container defining an internal space has an internal surface adjacent to the internal space. The inner surface of the container is made of a substance containing one or more kinds of polypropylene, polyethylene, and ionomer resin. A volume of fluoroether-containing inhalation anesthetic is contained in the inner space of the container. The invention is also directed to a method of storing inhaled anesthetics. This method includes the step of providing a predetermined volume of fluoroether-containing inhalation anesthetic. A container is also provided which is composed of a substance containing one or more polypropylene, polyethylene, and ionomer resins. This container defines the interior space. A predetermined volume of inhaled anesthetic containing fluoroether is placed in the inner space of the container. In a specific embodiment of the method of the present invention, a predetermined volume of a fluoroether-containing inhalation anesthetic is provided. In addition, a container is provided that has an inner surface defining an inner space. The inner surface of the container is made of a substance containing one or more kinds of polypropylene, polyethylene, and ionomer resin. A predetermined volume of inhaled anesthetic containing fluoroether is placed in the inner space of the container. Brief illustration

第8頁 470643 五、發明說明(4) 為更完全地了解本發明,可結合下面的詳述與所附圖解 作參考,其中: 圖1為根據本發明製造的醫藥產物的斷面觀。 本發明詳述 根據本發明製造的醫藥產物一般如圖1之10所示。醫藥 產物10包括有内表面14的容器12。内表面14包圍著容器12 内的内部空間1 6。吸入麻醉劑1 8裝於容器1 2的内部空間1 6 内。於本發明較佳具體實施例中,吸入麻醉劑1 8含氟醚化 合物。與本發明結合使用的含氟醚的吸入麻醉劑包括,但 不限於,七氟醚,安氟醚,異氟烷,曱氧氟烷,及得氟醚 (desflurane)。吸入麻醉劑18是液體,可包括液體相,汽 相,或液體相及汽相。圖1所示的吸入麻醉劑1 8是液體 相。 容器1 2的目的在裝吸入麻醉劑1 8。於本發明圖1所示具 體實施例中,容器1 2為瓶狀。然而要了解到,容器1 2可有 各種構形及容積,而仍不離本發明精神及範圍。例如,容 器1 2可以是裝大容積(例如幾十或幾百公升)吸入麻醉劑1 8 的船的構形。此種船的斷面可以是方形,球形或橢圓形而 仍不離本發明範圍。 容器1 2較佳是用使汽傳送進出容器1 2最小的物料構成, 從而使由容器1 2的内空間1 6釋出的吸入麻醉劑1 8的量達最 低,也從而使由容器1 2外部環境進入内部空間1 6由而進入 吸入麻醉劑1 8的汽傳送,例如水蒸汽傳送,達最小。容器 1 2也較佳是由不促使吸入麻醉劑1 8降解的物料構成。此Page 8 470643 V. Description of the invention (4) For a more complete understanding of the present invention, reference may be made to the following detailed description and accompanying drawings, wherein: FIG. 1 is a cross-sectional view of a pharmaceutical product manufactured according to the present invention. Detailed description of the invention The pharmaceutical products made according to the invention are generally shown in Figs. The medicinal product 10 includes a container 12 having an inner surface 14. The inner surface 14 surrounds the inner space 16 inside the container 12. The inhalation anesthetic 18 is contained in the internal space 16 of the container 12. In a preferred embodiment of the invention, the inhaled anesthetic 18 is a fluoroether compound. The fluoroether-containing inhalation anesthetics used in connection with the present invention include, but are not limited to, sevoflurane, enflurane, isoflurane, triflurane, and desflurane. The inhalation anesthetic 18 is a liquid and may include a liquid phase, a vapor phase, or a liquid phase and a vapor phase. The inhalation anesthetic 18 shown in Fig. 1 is a liquid phase. The purpose of the container 1 2 is to hold the inhaled anesthetic 18. In the specific embodiment shown in FIG. 1 of the present invention, the container 12 is bottle-shaped. However, it should be understood that the container 12 may have various configurations and volumes without departing from the spirit and scope of the present invention. For example, the container 12 may be in the configuration of a ship containing a large volume (eg, tens or hundreds of liters) of inhaled anesthetic 18. The cross section of such a ship may be square, spherical or oval without departing from the scope of the invention. The container 12 is preferably made of a material that minimizes the transmission of vapors into and out of the container 12, so that the amount of inhaled anesthetic 18 released from the internal space 16 of the container 12 is minimized, and thus the external of the container 12 The environment enters the internal space 16 and thus enters the vapor transmission of the inhaled anesthetic 18, such as water vapor transmission, to a minimum. The container 12 is also preferably composed of a material that does not promote degradation of the inhaled anesthetic 18. this

第9頁 470643Page 9 470643

發明說明(5) _ 外,容器12較佳是由在儲存、 破碎的物料構成。 輪及使用期間容器1 2不會 現已發現’由含聚乙烯萃_ 用於裝吸入麻醉劃時,;物料構成的容器在 用,及強度特徵…般此礙’化學交互作 酸酯有很多種,:i分子量,六#解到’聚乙烯萘二甲 不相同。這類聚;物可分為;:;·物即及^ 摻合物。現已知,聚乙稀蓉_ . P句聚物,/、聚物,與 合物相比,對汽傳送能提供:^聚物與共聚物及摻 會了解到,某*聚奈二甲酸醋均聚物。然而也 本發明,先決條件是苴g J酯共聚物及摻合物可用於 有適宜的傳送阻礙,^ _春、、五^,如吸入麻醉劑及水汽, 麻醉劑1 8無交互作用。 '、,、件是其有所需強度及吸入 外含汽阻礙特徵 於由此物料所構成的六。。 f 士 I,所以也不會使裝 降解的危險。 、谷益、έ氟醚的吸入麻醉劑有發生 可用於本發明的聚乙 __Description of the invention (5) _ In addition, the container 12 is preferably composed of materials that are stored and broken. During the cycle and the use of the container 1 2 will not now find 'contained by polyethylene extract _ used for inhalation anesthesia pads; containers made of materials are in use, and strength characteristics ... so this hinder' chemical interactions have many acid esters Species :: i molecular weight, six # solution to 'polyvinyl naphthalene is not the same. This kind of polymer can be divided into :: · 物 is and ^ blend. It is now known that, compared with the compound, the poly (ethylene) _. P sentence polymer, /, polymer, compared to the compound, can provide vapor transport: ^ polymer and copolymer and blending will understand that a certain polynaphthalic acid Vinegar Homopolymer. However, according to the present invention, the prerequisite is that the 苴 g J ester copolymer and blend can be used to have suitable transmission obstacles, such as inhalation of anesthetic and water vapor, and the anesthetic 18 has no interaction. ',,, and pieces are characterized by their required strength and resistance to inhalation and vapor containment. . f Taxi I, so there is no danger of degradation of the package. Inhalation anesthesia agent of Gu, Gu Yi, and Deflurane has occurred. Polyethylene which can be used in the present invention __

HiPERTUFTM90〇〇〇聚# t ;;、一甲酉夂酯物料的例是 品名),一種以聚/曰膝二月曰(She11 Chemical Company的商 甲酸醋。-般技藝者舍奈;;甲酸醋為基礎的2,6二甲基萘二 S旨也離不開本發gg φ & 到,使用其他聚乙烯萘二甲酸 於本發明第利Ϊ圍内所述的範圍。 、體貫施例中,容器1 2是由一層物料構HiPERTUFTM 90 〇〇〇〇 poly # t ;;, an example of monomethyl ester material is a product name), a poly / Yue Ji February February (She11 Chemical Company's commercial formic acid vinegar.-General artist Senna ;; formic acid vinegar The basic 2,6 dimethylnaphthalene diS is also inseparable from the present invention gg φ & to the use of other polyethylene naphthalenedicarboxylic acid in the range described in the scope of the present invention. The container 12 is composed of a layer of material

O:\57\57230.PTD 第10頁 五、發明說明(6) 成。即是,容器1 2的厚度是實質上 ~^ 例中,如前所述,容器丨2是由含乙—=。於此具體實施 構成。 _ .缔蔡一...圼〜酸S旨的物料 於本發明另一具體實施例中,容 謂多層一詞意為包括(i )由—層以° ^是多層的。此處所 少二層是由不同的物料構成,胃即的物料構成,其中至 同,或者是功能特徵不同的物料,I 、化學及結構性質不 或彼此排列成形成一單層;(丨丨 古、中各層是結合到一起 (i i i)有襯裡的物料,襯栩3八不同物料塗覆的物料; 述物料任何變化形式⑽料構成;及(卜)上 U的内表面14較佳是由含〒 具體實施例中,容器 應了解到,與含氟酿明Λ 烯沉—曱酸酯的物料構成。 含聚乙烯!二甲醆酯,以:::5觸的容器表面14較佳是 氣趟的吸入麻醉劑的降解可能減:最二礙特點並同時使含 的:::又—具體實施例中’ $器12是由含聚曱棊戊烯 ^。於較佳具體實施例中是用聚環曱基戊烯。可 Cz" ;,ι'明的聚甲基戍稀物料的例是"Daikyo Resin 賣。 '疋由 Dai kyo/Pharma-Gummi/West Croup 製造販 :由:Κίΐί戊豨物料。或者是’容器12的内表面14 Α 土戊烯的物料構成。於另一具體實施例中,内 衣面14可α阜、丄… 的Μ Λ疋与·樣的形式:(i)於不同物料如玻璃所界定 曱酸 覆内置以襯裡;或(丨1 )於不同物料所界定的體内施以塗 ϋ111)—層多層的物料,如上面討論聚乙烯蓄—田 曰曰所述者。O: \ 57 \ 57230.PTD Page 10 V. Description of Invention (6) Success. That is, the thickness of the container 12 is substantially ~ ^ In the example, as mentioned above, the container 丨 2 is made of containing B— =. Here, the structure is specifically implemented. In another embodiment of the present invention, the term “multi-layer” means to include (i) a multi-layer layer consisting of a layer and a layer. The two less layers here are composed of different materials, which are the materials of the stomach, which are the same or have different functional characteristics. I, chemical and structural properties are not aligned with each other to form a single layer; (丨 丨 古The middle layers are combined together (iii) lined materials, which are coated with different materials; any of the materials described above are made of concrete; and (b) the inner surface 14 of the upper U is preferably composed of 〒 In specific embodiments, the container should be understood to be composed of a material containing fluorine-containing fenene succinate-acetate. Containing polyethylene! Dimethyl ester, the surface 14 of the container that is in contact with :: 5 is preferably gas. Degradation of inhaled anesthetics may be reduced: the two most impediments to the characteristics and at the same time containing ::: again-in the specific embodiment, '$ 器 12 is composed of polyprenyl ^. In the preferred embodiment is used Polycyclopentyl pentene. Cz ", an example of a polymethyl fluorene thin material is sold by Daikyo Resin. '疋 is manufactured by Dai kyo / Pharma-Gummi / West Croup. By: Κίΐίpent豨 Material. Or 'inner surface 14 Α container of pentene. In a specific embodiment, the underwear surface 14 may be in the form of M Λ 疋, α, 丄, and the like: (i) different materials, such as glass, which are defined by glass, are lined with lining; or (丨 1) in different materials The defined body is coated with Tu 111) —multi-layered materials, as discussed above for polyethylene storage—Tian Yueyue.

第11頁 五、發明說明(7) 於本發明第二具體實施例中,容《 a 丙烯,聚乙烯,及離子鍵樹脂的物料』:由::,多種聚 12的内表面14是由聚丙烯,聚乙烯及離=疋,容15 DuPont所製的SURLYN離子鍵樹脂的物t構^ 神 ”離奋子鍵樹脂11 -詞意為離子交聯的熱,聚合物。二二斤: 體實施例中,内表面1 4可以是這樣的 σ ; 八 如玻璃所界定的體内置以襯裡;或(仏=於不同物料 乙稀蔡二甲ΐί所i:。…層的物料’如上面討論聚 面二解到,可用各種已知技術於容器12内表 f::較佳的技術可視⑴構成容器12所用物料.: (11)要施於容器12上的冷萝从ifeLjtLA 叶’及 曰士 ΡΑ ΛΛ 的塗覆物枓而定。例如,如果容考1〇 ί去的璃物料構A,可將容器12加熱到至少要塗f t去的主覆物料的熔點以使容器12内表面作。復 的塗覆物C於加熱的容器12上,例如藉將霧化 ^ ^ 表面。然後將容器冷至塗覆物料的溶 以下藉以使塗霜物判· $ &留尽·點 面“。 $復物枓形成早-的不破的膜或層,即内表 士圖1所* ,容器1 2界定出開α 2 〇 。開口 2 〇可用以# > 容器12並用t乂使用μ /㈤J _裝滿 哭1 9细从βπ〜便用 1 2裡的内各物,由而在需要時將外 成可封閉開口 2 0 ’由而封閉容器1 2内的吸 Γΐ 口 20 a ·,合物取出。如圖1所示本發明具體實施例中,I L明:::。但應了*,開口2〇可有各種構形而仍不離 蓋22是構邊 4、-pPage 11 V. Description of the invention (7) In the second embodiment of the present invention, "a material of propylene, polyethylene, and ionomer resin": by ::, the inner surface 14 of the poly 12 is made of poly Propylene, polyethylene, and ion = 疋, capacity 15 DuPont SURLYN ionomer resin structure ^ God "liquid bond resin 11-the word means the heat of ionic crosslinking, polymer. Two pounds: body In the embodiment, the inner surface 14 may be such that σ; the body defined by glass is built with a lining; or (仏 = in different materials, such as Cai Dijia 所) i: ... the material of the layer 'as discussed above In the second solution, various known techniques can be used in the container 12. Table f :: The better technique can be used to construct the materials used in the container 12. (11) The cold lollies to be applied to the container 12 ΛΛ depends on the coating material. For example, if the glass material structure A is removed, the container 12 can be heated to at least the melting point of the main coating material to be coated to make the inner surface of the container 12 repeat. The coating C on the heated container 12, for example by atomizing the surface. Then the container is cooled to the coating material So that the coating can be judged as follows: $ & leave it out · point surface ". $ 复 物 枓 forms an early-breaking film or layer, which is shown in Figure 1 of the inner surface *, and the container 12 defines the opening α 2 〇. The opening 2 〇 can be used for the container 12 and use t / use μ / ㈤ J _ filled with crying 1 9 fine from βπ ~ then use 12 inside the contents, so that the outer can be closed when needed The opening 20 'closes the suction port 20a in the container 12, and the compound is taken out. As shown in FIG. 1, in the specific embodiment of the present invention, IL is clear ::. But it should be *, the opening 20 may There are various configurations without leaving the cover. 22 is the edge 4, -p

〇-A57\57230.PTO 第12頁 470643 丨五、發明說明(8) ,私j 1 6。盍2 2可用各種已知物料構成。但較佳是,蓋2 2 疋由π傳送減至最少的物料以及使吸入麻醉劑】6之降解達 最低的物料構成。於本發明較佳具體實施例中,蓋22有内 表面24 ’此内表面是由含聚乙締笞二 於另-本發明具體實施例令 97物卄稱成 含聚丙稀,聚乙婦,及/或離,二及二其内表面24是由 料的汽阻礙特徵足以減少水汽及曰,物料構成,此物 送減至最小。於又一本發明具體實=二:劍的透過它的傳 内表面24是由含聚甲基戊烯的物祖:上 ’蓋22及/或其 竹稱成。她+ 到,蓋22及/或其内表面24可由聚丙稀,〜之’應了解 舊二曱酸酯,聚曱基戊烯,離子交 A乙烯,聚乙烯 成。如上討論容器1 2所述,蓋22的:二^,及其混合物構 可是多層的。 ”生貝可以是均質的,也 蓋22及容器12可建構成蓋22可以螺y 的容器及蓋是週知的。蓋22及容器u $於其上。此型 是一般有關技術人員所易於了解的。此 些具體貫施例 例包括,但不限於,可扣於容器上的苔*,、其他的具體實施 蓋,或用已知機械,如套環,裝於容器上黏於容器上的 較佳具體實施例中,蓋2 2與容器丨2的二;,蓋。於本發明 器12上取下而對蓋22或容器12不形成’盡22可從容 讓使用者由容器1 2内取出所需容積生知害,由而可 用蓋2 2將開口 2 0封閉。 麻醉劑1 8後,再 容器1 2還巧包括不構成本發明一部分士 器12可以是這樣的構形:將吸入麻醉刀、特點。例如’容 叶⑷8由容器12投送至〇-A57 \ 57230.PTO Page 12 470643 丨 V. Description of Invention (8), Private j 1 6盍 22 can be composed of various known materials. Preferably, however, the lid 2 2 疋 is made of a material that minimizes the π transfer and a material that minimizes the degradation of the inhaled anesthetic agent 6. In a preferred embodiment of the present invention, the cover 22 has an inner surface 24 'This inner surface is made of polyethylene-containing material. Another embodiment of the present invention makes 97 objects called polypropylene-containing, polyethylene-containing, And / or away, the inner surface 24 of the second and second parts is made of vapor barrier characteristics of the material enough to reduce water vapor, and the material is composed, and the material delivery is minimized. In another embodiment of the present invention, the second aspect is: the transmission of the sword through it. The inner surface 24 is made of a polymethylpentene-containing progenitor: the upper cover 22 and / or its bamboo. She added that the cover 22 and / or its inner surface 24 may be made of polypropylene, and it should be understood that the old diphosphonate, polyfluorenylpentene, ionomer ethylene, polyethylene. As discussed in the discussion of the container 12, the cover 22: 2 ^, and mixtures thereof may be multilayered. The raw shell can be homogeneous, and the lid 22 and the container 12 can be constructed to form a container and a lid that can be screwed on the lid. It is well known. The lid 22 and the container are on it. This type is easy for a person skilled in the art to understand. These specific examples include, but are not limited to, moss that can be fastened on the container, other specific implementation caps, or those that are attached to the container by a known mechanism such as a collar. In a preferred embodiment, the lid 22 and the container 2 are removed from the container 12 of the present invention without forming the lid 22 or the container 12. The required volume is taken out to cause harm, so that the opening 20 can be closed with the lid 22. After the anesthetic 18, the container 12 also happens to include a twelve vessel 12 which does not form part of the present invention. Knives, features, such as' Rong Ye Zhi 8 delivered from container 12 to

第13頁 470643 五、發明說明(9) 麻醉汽化器的構形。如發給G r a b e n k 〇 r t的義疏士 5, 5 0 5, 23 6號所揭示者。 〜 製造用於本發明的容器的方法是已知的。例 聚乙烯f二曱酸酯在使用前必須乾燥至約〇,⑼’現已知 以適合於容器1 2及蓋2 2的物理性質。用於本凝^ 。的濕度’ 器1 2及蓋22的較佳方法是將含聚乙晞賓二甲妒,的製造容 噴射-拉伸-吹(丨111)’6(:1:丨〇11-51^61:仏-131〇\〇成^知的物料作 Technical Laboratory, Inc. of Tokyo 〗^ °A〇KI 機械作此種成形特別有用。將含聚乙烯零二apan所製的 注射至模型内成形,然後移至吹台,在$:曱峻酯的物料 容器。然後將此容器成批加熱,於對流爐;^妆、吹形成 現已發現,將含聚乙烯零二曱酸酯的物ij火。 物料的結晶度單作吹成形所不能達到的程'戶以火可增加此 加形成汽傳送南阻礙,因而增強含取7 ^ 、'’0晶度的增 火物料的汽阻礙性。結晶度的增加也減輕=—甲酸酯的退 (以達成所需容器強度的重量為基礎)及=谷器1 2的總重量 的容器1 2所用物料的量。容器強度的辦衣成所需容器強度 輸、儲存及使用過程中承受較大載荷7 =可使容器在運 最低。例如,當容器1 2在運輸或儲^ ±攸而使容器破碎達 時,或成箱的容器12 —個個疊起來B± 4須—個個疊起來 度。應注意到,由含退火的聚乙烯^,即需較大的容器強 容器較有相同強度的玻璃容器為輕π 一曱酸酯物料構成的 容器不易破碎,在製造成本上也較有,車父相同重量的玻璃 為低。較輕的容器重量也減少容器 目同特點的玻璃容器 π建輪所用成本。此外, 470643 五、發明說明(10) 此種容器也不 本發明方 的步驟。此含 醚’安氟醚, (desf1urane ) 特定地說,容 曱酸酯物料構 12的内表面14 多層聚乙烯蓄 述過。本發明 劑1 6置於容器 於另一本發 醚的吸入麻醉 多種七氟趟, (desf1urane ) 地說,容器1 2 構成,其中聚 可以具容器1 2 的内表面1 4, 積的含氟醚的 内。 於本發明方 醚的吸入麻醉 多種七氟醚, 像玻璃容 包括提供 氟謎的吸 異氟炫, 。也提供 器1 2界定 成的,其 上’其可 二曱酸酯 方法還包 所界定的 明方法具 劑1 6。此 安氟喊, 。也提供 界定内部 甲基戊稀 均質物料 此點已如 吸入麻醉 器會使含氟 預定容積的 入麻醉劑1 6 曱氧氟烷, 根據上述醫 出内部空間 中聚乙烯t 以具容器1 2 構成的内表 括將預定容 内部空間内 體實施例中 含氟醚的吸 異氟烷,甲 根據上述產 空間,且是 是存在於容 特徵,或是 上述。本發 劑1 6置於容 喊的吸入 含氟醚的 可以是— 及得氟醚 藥產物構 ,且是由 二甲酸酯 均質物料 面1 4,此 積的含氟 〇 ,提供預 入麻醉劑 氧氟烷, 物構成的 由含聚曱 器1 2的内 由多層聚 明方法還 器所界定 麻醉劑 吸入麻 或多種 成的容 含聚乙 是存在 特徵, 點已於 喊的吸 定容積 16可以 及得氟 容器12 基戊烯 表面1 4 曱基戊 包括將 的内部 降解。 醉劑U 七氟 器1 2。 烯琴- TTt 於容器 或是由 上面敛 入麻醉 的含氟 是一或 喊 。特定 的物料 上,其 烯構成 預定容 空間 的含氟 是一或 鍵 法另一具體實施例中,提供預定容積 劑1 6。此含氟醚的吸入麻醉劑丨6可以 女氟醚,異氟烷,曱氧氟烷,及得氟Page 13 470643 V. Description of the invention (9) Configuration of anesthesia vaporizer. As issued to G r a b e n k 〇 r t of Yi Shu Shi 5, 5 0 5, 23 6 disclosed. ~ A method for manufacturing a container for use in the present invention is known. Example The polyethylene f-diphosphonate must be dried to about 0 before use, which is now known to be suitable for the physical properties of container 12 and lid 22. Used in this condensation ^. The preferred method for the humidity device 1 2 and the cover 22 is to spray-stretch-blow (丨 111) '6 (: 1: 丨 〇11-51 ^ 61 : 仏 -131〇 \ 〇 成 ^ Known materials for Technical Laboratory, Inc. of Tokyo 〖^ ° A〇KI Machine is particularly useful for this type of molding. Injection made of polyethylene zero two apan into the mold, Then move to the blowing table in the material container of $: 曱 Jun ester. Then heat this container in batches in a convection oven; ^ makeup, blowing to form it has been found that The degree of crystallinity of the material can not be achieved by single blow molding. The use of fire can increase this addition and form a barrier to vapor transmission, thereby enhancing the vapor barrier of the flame-increasing material with a crystallinity of 7 ^ `` 0 ''. Crystallization The increase of the degree also reduces the amount of material used for the container 1 2 which is the return of the formate (based on the weight to achieve the required container strength) and the total weight of the trough 1 2. The strength of the container during the load, storage and use of a large load 7 = can make the container in the lowest transport. For example, when the container 1 2 in transport or storage ^ ± When the container is broken up, or the box of the container 12-one stacked B ± 4 shall be stacked one by one. It should be noted that from annealed polyethylene ^, a larger container is required to have a stronger container. The glass container of the same strength is made of light π monoacetate material, which is not easy to break, and the manufacturing cost is also relatively high. The glass of the same weight of the driver is low. The lighter container weight also reduces the glass container with the same characteristics. π The cost for the construction of the wheel. In addition, 470643 V. Description of the invention (10) This type of container is also not an inventor's step. This ether's anflurane (desfurane), specifically, the acyl ester material structure 12 The inner surface 14 is described by multilayer polyethylene. The agent 16 of the present invention is placed in another container of inhaled anesthesia and various sevoflurane, (desf1urane), that is, the container 1 2 is formed, and the polymer can be provided with the container 1 2 The inner surface of the product is fluorinated ether. The inhaled anesthesia in the square ether of the present invention is a variety of sevoflurane, such as glass container, which includes inhaled isoflurane, which provides a fluorine puzzle. On it's can diacetate side The method also includes a clear method defined by the agent 16. This fluorofluoride also provides a homogeneous material that defines the internal methylpentane. This point has been achieved by inhaling the anesthetic device with a predetermined volume of fluorine containing anesthetic agent 16 6 According to the above-mentioned medical treatment, the polyethylene t in the internal space is composed of a container 12 and the inner volume includes a predetermined volume of the internal space of the inner space embodiment of the isoflurane-absorbing isoflurane. A is based on the above-mentioned production space, and is Exist in the capacity characteristics, or the above. The inhaling fluoroether of this hair agent 16 can be-and get the fluoroether drug product structure, and it is composed of the diformate homogeneous material surface 14 Fluorine, which provides pre-anesthetized oxyflurane, is composed of a polycontainer 12 and an inner layer is defined by a multi-layer polyamine method. The inhalation of anesthesia or multi-component containing polyethylene is an existing feature. Yu's aspiration volume of 16 can reach the fluorine container 12 based on the surface of pentene 1 4 fluorenyl includes the internal degradation. Intoxicant U Heptafluoride 1 2. Allen-TTt is contained in a container or is anesthetized with fluorine containing one or shout. On a specific material, the fluorinated olefin containing a predetermined volume of space is a one-or-bond method. In another specific embodiment, a predetermined volume of agent 16 is provided. This fluoroether-containing inhalation anesthetic 丨 6 can be female fluoroether, isoflurane, triflurane, and fluorine

第15頁 五、發明說明(11) (desf1urane ) 地說,容器1 2 烯,聚乙烯, 容器1 2之内表 由多層所述物 方法還包括將 所界定的内部 應了解到, 構成。 。也提供根據上述產物構成的容器12。特定 界定内部空間16 ’且是由含-或多種聚丙 及離子鍵樹脂的物料構成,其中所述物料是 面14上,可以具容器丨2均質物料特徵,或是 料,,的内表面14,此點已如上述。本發明 預定容積的含氟醚的吸入麻醉劑丨6置於容器 空間内。 谷器1 2及其内表面丨4可由一或多種上述物料 於每一本發 口 2 0, 境之間 包括提 烯蓄二 於另一 或多種 酯,及 封閉由 雖則 產物及 改而仍 神及範 以此開 的液體 供由含 甲酸酯 步驟中 聚丙烯 聚甲基 容器1 2 此處已 方法, 不離如 圍。 明方法具體實施例 口 2 0提供容器丨2内 父通。於每一本發 —或種聚丙烯,聚 ’及聚甲基戊烯的 ,蓋2 2可這樣構成 ’、聚乙烯,離子鍵 戊烯的物料構成。 界定的開口的方法 用特定的較佳具體 般此技藝人員會 此處所附申請專利 中,容器1 2可界 部空間1 6及容器 明方法具體實施 乙歸,離子鍵樹 物料構成的蓋2 2 ,使其内表面2 4 樹脂,聚乙烯著 本發明方法還包 實施例說明了本 瞭解本發明還可 定出其開 1 2外部環 例中,還 脂,聚乙 的步驟。 是由含一 二甲酸 括以蓋22 發明醫藥 作各種修 範圍内所揭示的本發明精Page 15 V. Description of the invention (11) (desf1urane) In other words, the container 1 2 ene, polyethylene, and the internal surface of the container 12 are made of multiple layers. The method also includes defining the interior of the container. . A container 12 constructed from the above product is also provided. A specific defined internal space 16 ′ is composed of a material containing-or a plurality of polypropylene and ionomer resins, wherein the material is on the surface 14 and may have the characteristics of a container 丨 2 homogeneous material, or the inner surface 14 of the material, This is already as described above. A predetermined volume of the fluoroether-containing inhalation anesthetic agent of the present invention is placed in a container space. The trough 1 2 and its inner surface 4 can be made of one or more of the above materials at each hair outlet 20, and the environment includes the extraction of diene and storage of two or more esters. And the liquid prepared in this way is provided by the polypropylene polymethyl container 1 2 in the formate-containing step, and the method has been performed here. A specific embodiment of the method is provided in the container 2 to communicate with the parent. In each hair-or polypropylene, poly 'and polymethylpentene, the cover 22 can be formed as such', polyethylene, and the material of the ion-bonded pentene. The method of defining the opening is specific and specific. The artist will attach the patents attached here. The container 12 can be bounded by the space 16 and the container method is specifically implemented. The cover made of ionic key tree material 2 2 The inner surface is made of 2 4 resin and polyethylene. The method of the present invention also includes an example to explain the understanding of the present invention. It can also determine the steps of opening the outer ring of 1 2 and reducing the fat and polyethylene. It is the essence of the present invention disclosed in the scope of

弟16頁Brother page 16

Claims (1)

4706_ :f| I _88105523_知年/(月 日 修正_ 六、申請專利範圍 1 . 一種吸入性麻醉劑產品,其包括: 一容器,其由含選自包括聚乙烯萘二甲酸酯 (polyethylene naphthalate),聚甲基戊稀,聚丙稀,聚 乙稀,離子鍵樹脂化合物,及其混合物的物料所構成,該 容器界定出内部空間;及 有容積之七氟醚,其裝於該容器界定出的内部空間内。 2. 根據申請專利範圍第1項之產品,其中該容器界定出 其開口 ,該開口提供該容器之該内部空間及該容器之外部 環境之間的液體交通,該含七氟醚之物件尚包括蓋,該蓋 之構成用以封閉該容器所界定的開口 ,該蓋含有的物料選 自包括聚丙烯,聚乙烯,離子鍵樹脂,聚乙烯萘二曱酸 酯,及聚甲基戊烯的化合物及其混合物。 3. 根據申請專利範圍第1項之產品,其中該容器界定出 其開口 ,該開口提供該容器之該内部空間及該容器之外部 環境之間的液體交通,該含七氟醚之物件尚包括有内表面 的蓋,該蓋之構成用以封閉該容器所界定的該開口 ,該蓋 的該内表面是由含有選自包括聚丙烯,聚乙烯,聚乙烯萘 二曱酸酯,聚曱基戊烯,離子鍵樹脂的化合物及其混合物 的物料構成。 4. 一種吸入性麻醉劑產品,其包括: 一界定出内部空間的容器,該容器之内表面與該内部空 間相鄰,該内表面是由含選自包括聚乙烯萘二甲酸酯,聚 甲基戊烯,聚丙烯,聚乙烯,離子鍵樹脂化合物及其混合 物的物料構成;及4706_ : f | I _88105523_ Zhinian / (Month and Day Amendment _) 6. Application for patent scope 1. An inhalation anesthetic product comprising: a container containing a material selected from the group consisting of polyethylene naphthalate ), Consisting of polymethylpentane, polypropylene, polyethylene, ionomer resin compounds, and mixtures thereof, the container defines an internal space; and a sevoflurane having a volume, which is defined in the container, defines 2. The product according to item 1 of the scope of patent application, wherein the container defines an opening which provides liquid communication between the internal space of the container and the external environment of the container. The ether article also includes a lid which is configured to close the opening defined by the container. The lid contains materials selected from the group consisting of polypropylene, polyethylene, ionomer resin, polyethylene naphthalate, and polymethylene Compounds based on pentene and mixtures thereof. 3. The product according to item 1 of the scope of patent application, wherein the container defines an opening which provides the internal space of the container and the container. For liquid communication between the external environment, the sevoflurane-containing article further includes a cover with an inner surface, the cover is configured to close the opening defined by the container, and the inner surface of the cover is Material composition including polypropylene, polyethylene, polyethylene naphthalate, polypentylpentene, ionomer resin compounds and mixtures thereof 4. An inhalation anesthetic product comprising: A container having an inner surface adjacent to the inner space, the inner surface being composed of a material selected from the group consisting of polyethylene naphthalate, polymethylpentene, polypropylene, polyethylene, ionomer resin compounds, and mixtures thereof Material composition; and O:\57\57230.ptc 第1頁 2001.06.12.018 470643 _案號88105523_p年‘月 曰 修正_ 六、申請專利範圍 有容積的七氟醚,其裝於該容器内。 5 .根據申請專利範圍第4項之產品,其中該容器界定出 其開口 ,該開口提供該容器之該内部空間及該容器之外部 環境之間的液體交通,該含七氟醚之物件尚包括蓋,該蓋 之構成用以封閉該容器所界定的開口 ,該蓋含有的物料選 自包括聚丙烯,聚乙烯,離子鍵樹脂,聚乙烯萘二甲酸 酯,及聚曱基戊烯的化合物及其混合物。 6. 根據申請專利範圍第4項之產品,其中該容器界定出 其開口 ,該開口提供該容器之該内部空間及該容器之外部 環境之間的液體交通,該含七II醚之物件尚包括有内表面 的蓋,該蓋之構成用以封閉該容器所界定的該開口 ,該蓋 的該内表面是由含有的物料選自包括聚丙烯,聚乙烯,聚 乙烯萘二甲酸酯,聚曱基戊烯,離子鍵樹脂的化合物及其 混合物的物料構成。 7. —種儲存七氟醚的方法,該方法包括步驟: 提供預定容積的七氟醚; 提供界定出内部空間的容器,該容器是由含選自聚乙二 稀萘二曱酸酯,聚甲基戊稀,聚丙烯,聚乙稀,離子鍵樹 脂化合物及其混合物的物料構成;及 將該預定容積的該七氟醚置於該容器所界定出内部空間 内。 8. 根據申請專利範圍第7項之儲存七氟醚的方法,其中 該容器界定出其開口 ,該開口提供該容器所界定出的該内 部空間及該容器之外部環境之間的液體交通,該方法尚包O: \ 57 \ 57230.ptc Page 1 2001.06.12.018 470643 _Case No. 88105523_p Year 『Month』 Amendment _ Sixth, the scope of patent application There is a volume of sevoflurane in this container. 5. The product according to item 4 of the scope of patent application, wherein the container defines an opening which provides liquid communication between the internal space of the container and the external environment of the container. The sevoflurane-containing article also includes A lid configured to close an opening defined by the container. The lid contains materials selected from compounds including polypropylene, polyethylene, ionomer resin, polyethylene naphthalate, and polypentylpentene. And its mixture. 6. The product according to item 4 of the scope of patent application, wherein the container defines an opening which provides liquid communication between the internal space of the container and the external environment of the container. The object containing hepta-II ether also includes A lid having an inner surface configured to close the opening defined by the container, the inner surface of the lid is made of a material selected from the group consisting of polypropylene, polyethylene, polyethylene naphthalate, and poly Lithylpentene, a compound of ionomer resin and its mixture. 7. A method for storing sevoflurane, the method comprising the steps of: providing a predetermined volume of sevoflurane; providing a container defining an internal space, the container being made of a material containing polyethylene naphthalate, Material composition of methylpentane, polypropylene, polyethylene, ionic resin compounds and mixtures thereof; and placing the predetermined volume of the sevoflurane in an internal space defined by the container. 8. The method for storing sevoflurane according to item 7 of the scope of patent application, wherein the container defines an opening that provides liquid communication between the internal space defined by the container and the external environment of the container, the Method package O:\57\57230.ptc 第2頁 2001.06.12.019 470643 _案號88105523_^年έ月 曰 修正_ 六、申請專利範圍 括的步驟是: 提供構成用以封閉由該容器所界定的該開口的蓋,該蓋 是由含選自包括聚丙烯,聚乙烯,聚乙烯萘二甲酸酯,聚 曱基戊烯,離子鍵樹脂的化合物及其混合物的物料構成; 及 用該蓋封閉由該容器所界定出的該開口。 9.根據申請專利範圍第7項之儲存七氟醚的方法,其中 該容器界定出其開口 ,該開口提供該容器所界定出的該内 部空間及該容器之外部環境之間的液體交通,該方法尚包 括的步驟是: 提供構成用以封閉由該容器所界定的該開口的蓋,該蓋 之内表面是由含選自包括聚丙烯,聚乙烯,聚乙烯萘二曱 酸酯,聚甲基戊烯,離子鍵樹脂的化合物及其混合物的物 料構成;及 用該蓋封閉由該容器所界定出的該開口。 1 0. —種儲存七氟醚的方法,該方法包括步驟: 提供預定容積的七氟醚; 提供界定出内部空間的容器,該容器的内壁與該容器界 定出的該内部空間相鄰,該容器的該内壁是由選自包括聚 乙二烯萘二甲酸酯,聚曱基戊烯,聚丙烯,聚乙烯,離子 鍵樹脂化合物及其混合物的物料構成;及 將該預定容積的七氟醚置於該容器所界定出内部空間 内。 1 1 .根據申請專利範圍第1 0項之儲存七氟醚的方法,其O: \ 57 \ 57230.ptc Page 2 2001.06.12.019 470643 _ Case No. 88105523_ ^ year month month amendment _ 6. The steps included in the scope of the patent application are: to provide a structure to close the opening defined by the container A lid made of a material containing a compound selected from the group consisting of polypropylene, polyethylene, polyethylene naphthalate, polypentyl pentene, ionomer resin, and a mixture thereof; and the container closed by the lid The opening defined. 9. The method for storing sevoflurane according to item 7 of the scope of patent application, wherein the container defines an opening that provides liquid communication between the internal space defined by the container and the external environment of the container, the The method further includes the steps of: providing a lid constituting to close the opening defined by the container, and the inner surface of the lid is made of a material selected from the group consisting of polypropylene, polyethylene, polyethylene naphthalate, and polymethyl A material consisting of a pentene, a compound of an ionomer resin, and a mixture thereof; and closing the opening defined by the container with the lid. 1 0. A method for storing sevoflurane, the method comprising the steps of: providing a predetermined volume of sevoflurane; providing a container defining an internal space, an inner wall of the container being adjacent to the internal space defined by the container, the The inner wall of the container is composed of a material selected from the group consisting of polyethylene dinaphthalene, polypentyl pentene, polypropylene, polyethylene, ionomer resin compounds, and mixtures thereof; and the predetermined volume of heptafluoro The ether is placed in the interior space defined by the container. 1 1. A method for storing sevoflurane according to item 10 of the scope of patent application, which O:\57\57230.ptc 第3頁 2001.06.12.020 470643 _案號88105523_^年么月 曰 修正_ 六、申請專利範圍 中該容器界定出其開口 ,該開口提供該容器所界定出的該 内部空間及該容器之外部環境之間的液體交通,該方法尚 包括的步驟是: 提供構成用以封閉由該容器所界定的該開口的蓋,該蓋 是由含選自包括聚丙烯,聚乙烯,聚乙烯萘二曱酸酯,聚 曱基戊烯,離子鍵樹脂的化合物及其混合物的物料構成; 及 用該蓋封閉由該容器所界定出的該開口。 1 2.根據申請專利範圍第1 0項之儲存七氟醚的方法,其 中該容器界定出其開口 ,該開口提供該容器所界定出的該 内部空間及該容器之外部環境之間的液體交通,該方法尚 包括步驟: 提供構成用以封閉由該容器所界定的該開口的蓋,該蓋 之内表面是由含選自包括聚丙烯,聚乙烯,聚乙烯萘二曱 酸酯,聚甲基戊稀,離子鍵樹脂的化合物及其混合物的物 料構成;及 用該蓋封閉由該容器所界定出的該開口。O: \ 57 \ 57230.ptc Page 3, 2001.06.12.020 470643 _ Case No. 88105523_ ^ year month month amendment _ VI. In the scope of the patent application, the container defines its opening, and the opening provides the interior defined by the container For the liquid communication between the space and the external environment of the container, the method further comprises the steps of: providing a cover constituting to close the opening defined by the container, the cover is made of , Polyethylene naphthalate, polypentyl pentene, an ion-bonded resin compound, and a mixture thereof; and the lid is used to close the opening defined by the container. 1 2. The method for storing sevoflurane according to item 10 of the scope of patent application, wherein the container defines an opening which provides liquid communication between the internal space defined by the container and the external environment of the container The method further comprises the steps of: providing a lid configured to close the opening defined by the container, and the inner surface of the lid is made of a material selected from the group consisting of polypropylene, polyethylene, polyethylene naphthalate, and polymethyl A material consisting of a dipentyl, an ion-bonding resin compound and a mixture thereof; and closing the opening defined by the container with the lid. O:\57\57230.ptc 第4頁 2001.06.12.021O: \ 57 \ 57230.ptc Page 4 2001.06.12.021
TW88105523A 1998-12-04 1999-04-07 A sevoflurane-containing article and methods for storing sevoflurane TW470643B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/205,460 US6162443A (en) 1998-01-09 1998-12-04 Container for an inhalation anesthetic

Publications (1)

Publication Number Publication Date
TW470643B true TW470643B (en) 2002-01-01

Family

ID=22762278

Family Applications (1)

Application Number Title Priority Date Filing Date
TW88105523A TW470643B (en) 1998-12-04 1999-04-07 A sevoflurane-containing article and methods for storing sevoflurane

Country Status (5)

Country Link
AR (1) AR019364A1 (en)
PE (1) PE20000840A1 (en)
TW (1) TW470643B (en)
UY (2) UY25467A1 (en)
ZA (1) ZA99494B (en)

Also Published As

Publication number Publication date
PE20000840A1 (en) 2000-09-02
ZA99494B (en) 1999-07-22
AR019364A1 (en) 2002-02-13
UY25474A1 (en) 2001-07-31
UY25467A1 (en) 1999-11-17

Similar Documents

Publication Publication Date Title
AU732187B2 (en) Container for an inhalation anesthetic
JP5746002B2 (en) Container for inhalation anesthetic
ES2259601T3 (en) NEW USE
CN107049929B (en) Single dose pharmaceutical formulations of thyroid hormones T3 and/or T4
RU2381103C2 (en) Container for liquid pharmaceutical compositions with high moistureproof properties
US20140166527A1 (en) Inhalation Anesthetic Product
US6083514A (en) Polymethylpentene container for an inhalation anesthetic
TW470643B (en) A sevoflurane-containing article and methods for storing sevoflurane
AU2001290833A1 (en) Container for inhalation anesthetic
US6074668A (en) Container for an inhalation anesthetic
WO2003032890A1 (en) Container for an inhalation anesthetic
US20070221217A1 (en) Container for an inhalation anesthetic
TWI623310B (en) Packaged acetaminophen injection solution preparation
HRP20000521A2 (en) Container for an inhalation anesthetic
WO2009049460A1 (en) New packaging material for sevoflurane
MXPA00006735A (en) Container for an inhalation anesthetic
WO2006019795A9 (en) Container for an inhalation anesthetic
Lockhart et al. Packaging requirements of pharmaceuticals

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MK4A Expiration of patent term of an invention patent